Apellis Surges By Double Digits As FDA Mulls Its Eye-Disease Treatment

Apellis Surges By Double Digits As FDA Mulls Its Eye-Disease Treatment

Submitted by admin on July 19, 2022 - 10:14am
Source: 
Investors Business Daily
News Tags: 
Apellis Pharmaceuticals
geographic atrophy
FDA
pegcetacoplan
Headline: 
Apellis Surges By Double Digits As FDA Mulls Its Eye-Disease Treatment
snippet: 

The Food and Drug Administration accepted Apellis Pharmaceuticals' (APLS) application for an eye-disease treatment on Tuesday, leading APLS stock to surge.

Do Not Allow Advertisers to Use My Personal information